Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
86.6M
-
Number of holders
-
139
-
Total 13F shares, excl. options
-
46.4M
-
Shares change
-
+11.4M
-
Total reported value, excl. options
-
$1.03B
-
Value change
-
+$270M
-
Put/Call ratio
-
0.42
-
Number of buys
-
95
-
Number of sells
-
-32
-
Price
-
$22.24
Significant Holders of Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (SNDX) as of Q4 2020
157 filings reported holding SNDX - Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share as of Q4 2020.
Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (SNDX) has 139 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 46.4M shares
of 86.6M outstanding shares and own 53.65% of the company stock.
Largest 10 shareholders include Avidity Partners Management LP (3.31M shares), WELLINGTON MANAGEMENT GROUP LLP (2.62M shares), BlackRock Inc. (2.32M shares), BOXER CAPITAL, LLC (2.29M shares), CITADEL ADVISORS LLC (2.11M shares), EVENTIDE ASSET MANAGEMENT, LLC (1.95M shares), VANGUARD GROUP INC (1.85M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.83M shares), Nantahala Capital Management, LLC (1.8M shares), and STATE STREET CORP (1.7M shares).
This table shows the top 139 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.